The University of Queensland

A new class of inhibitors for the treatment of tuberculosis (NHMRC Project Grant administered by The University of Sydney) (2015–2017)

Abstract:

Tuberculosis (TB) remains a major cause of mortality and morbidity worldwide. This project will identify and characteristise new compounds with potential to treat drug resistant TB, with the ultimate goal of reducing treatment times and eliminating bacteria from those latently infected with M. tuberculosis. Achievement of this goal will have an enormous impact on world health and save many lives

Grant type:

University of Sydney

Researchers:

• 

  Associate Professor Nick West

  Associate Professor
  

  School of Chemistry and Molecular Biosciences

  Faculty of Science

Funded by:

The University of Sydney